11 – 20 of 141
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Statin use and risk of breast cancer among women with benign breast disease : a Danish nationwide cohort study
- Contribution to journal › Article
-
Mark
Global Transcriptional Complexity of Estrogen Receptor Low Positive Breast Cancers in a Prospective Swedish Population-based SCAN-B Cohort
(2025) In Clinical cancer research : an official journal of the American Association for Cancer Research 31(13). p.2695-2709
- Contribution to journal › Article
-
Mark
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
- Contribution to journal › Article
-
Mark
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
- Contribution to journal › Article
-
Mark
Navigating Immune Landscapes in Ovarian Cancer - Spatial and Genomic Insights into High-Grade Serous and Endometriosis-Associated Histotypes
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation
- Thesis › Doctoral thesis (compilation)
-
Mark
Advances in Risk Management and Screening for Women at Increased Risk of Breast Cancer: The Role of MR Imaging and Personalised Approaches
(2025) In Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine 24(3). p.403-418
- Contribution to journal › Scientific review
-
Mark
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT : a randomized clinical trial with long-term follow-up
- Contribution to journal › Article
-
Mark
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases
- Contribution to journal › Article
-
Mark
Balancing Environmental Sustainability and Nutrition: Dietary Climate Impact in Relation to Micronutrient Intake and Status in a Swedish Cohort
- Contribution to journal › Article
-
Mark
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation : Final overall survival results from the OPINION trial
- Contribution to journal › Article
